Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Prognostic Significance of Interim PET/CT Assessment for the Treatment of Advanced Stage of Marginal Zone Lymphoma in the Post Immunochemotherapy Era

Ga-Young Song, Seok Jin Kim, MD PhD, Sang Eun Yoon, Jin Seok Kim, MD PhD, Ho-Young Yhim, MD PhD, Youngil Koh, MD PhD, Sung Yong Oh, MD PhD, Ho Sup Lee, MD PhD, Ho-Jin Shin, MD PhD, Young Rok Do, MD PhD, Won Sik Lee, MD PhD, Lee Gyeong-Won, Dae Sik Kim, Yong Park, Deok-Hwan Yang, MD PhD

Blood (2019) 134 (Supplement_1): 4002.

https://doi.org/10.1182/blood-2019-126574

Published: 2019

Journal Articles

A Nationwide Epidemiologic Study for Disease Transformation and Secondary Cancers in Korean Patients with Myeloproliferative Neoplasms

Junshik Hong, MD, Ju Hyun Lee, Ja Min Byun, MD, Ji Yun Lee, MD, Hyun Jung Lee, MD, Sang Mee Hwang, MD PhD, Byung-Su Kim, MD PhD, Hyo Jung Kim, MD PhD, Jung Lim Lee, MD, Dong-Yeop Shin, MD PhD, Youngil Koh, MD PhD, Sung-Soo Yoon, MD PhD, Soo-Mee Bang, MD PhD

Blood (2018) 132 (Supplement 1): 4314.

https://doi.org/10.1182/blood-2018-99-116298

Published: 2018

Journal Articles

Genomic and Immune Profiles of Multiple Myeloma Revealed By Whole Genome and Transcriptome Sequencing

Christopher J. Yoon, MPhil, Hyojin Song, Seulki Song, Hyejoo Park, Dong-Yeop Shin, MD PhD, Junshik Hong, MD, Inho Kim, MD PhD, Hyun Jung Lee, MD, Byung-Su Kim, MD PhD, Jung Lim Lee, MD, Sung-Soo Yoon, MD PhD, Young Seok Ju, Youngil Koh, MD PhD

Blood (2018) 132 (Supplement 1): 4493.

https://doi.org/10.1182/blood-2018-99-117546

Published: 2018

Journal Articles

Mosunetuzumab, a Full-Length Bispecific CD20/CD3 Antibody, Displays Clinical Activity in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NHL): Interim Safety and Efficacy Results from a Phase 1 Study

Blood (2018) 132 (Supplement 1): 399.

https://doi.org/10.1182/blood-2018-99-118344

Published: 2018

Journal Articles

Exon Skipping of AIMP2 and Lymphomagenesis

Doyeun Kim, PhD, Seulki Song, Dae-Yoon Kim, Dongchan Kim, Nam Hoon Kwon, PhD, Byung-Su Kim, MD PhD, Hyun Jung Lee, MD, Hyo Jung Kim, MD PhD, Jung Lim Lee, MD, Sung-Soo Yoon, MD PhD, Yoon Kyung Jeon, MD PhD, Sunghoon Kim, Youngil Koh, MD PhD

Blood (2018) 132 (Supplement 1): 2630.

https://doi.org/10.1182/blood-2018-99-117596

Published: 2018

Journal Articles

Anticoagulation Treatment with Low Molecular-Weight Heparin for Portal Vein Thrombosis in Liver Cirrhosis: Efficacy and Risk of Hemorrhagic Complications

Jihyun Kwon, Youngil Koh, MD PhD, Jung-Hwan Yoon, Su jong Yu

Blood (2016) 128 (22): 1435.

https://doi.org/10.1182/blood.V128.22.1435.1435

Published: 2016

Journal Articles

A Phase II Trial of Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-Cell Lymphoma (BENCART): A Consortium for Improving Survival of Lymphoma (CISL) Trial

Byeong-Bae Park, Won Seog Kim, Cheolwon Suh, Dok Hyun Yoon, Jong-Ho Won, Deok-Hwan Yang, Young-Rok Do, Won Sik Lee, Jeong-A Kim, Min Kyoung Kim, Jae-Cheol Jo, MD PhD, Youngil Koh, MD PhD

Blood (2016) 128 (22): 1823.

https://doi.org/10.1182/blood.V128.22.1823.1823

Published: 2016

Journal Articles

Decitabine Is Superior to Cytotoxic Chemotherapy in Elderly Acute Myeloid Leukemia Patients in Terms of Medical Source Utilization and Cost-Effectiveness without Negatively Impacting Survival Outcomes

Youngil Koh, MD PhD, Young Ae Kim, PhD, Kyuwoong Kim, Jin-Ah Sim, Sung-Soo Yoon, MD PhD, Sang Min Park, Young Ho Yun

Blood (2016) 128 (22): 2381.

https://doi.org/10.1182/blood.V128.22.2381.2381

Published: 2016

Journal Articles

Real World Treatment Outcomes of Multiple Myeloma in Korea

Ja Min Byun, Sung-Soo Yoon, Dong-Yeop Shin, MD PhD, Youngil Koh, MD PhD, Inho Kim, MD PhD, Hyun Kyung Kim, Dong Soon Lee, Jung-Lim Lee, Byung Su Kim

Blood (2016) 128 (22): 2367.

https://doi.org/10.1182/blood.V128.22.2367.2367

Published: 2016

Journal Articles

Analysis of Adverse Events of Dasatinib and Nilotinib in Chronic Phase Chronic Myeloid Leukemia Patients Treated Outside Clinical Trials

Koung Jin Suh, Ji Yun Lee, Dong-Yeop Shin, MD PhD, Youngil Koh, MD PhD, Soo-Mee Bang, Sung-Soo Yoon, MD PhD, Seonyang Park, Inho Kim, Jeong-Ok Lee

Blood (2016) 128 (22): 1902.

https://doi.org/10.1182/blood.V128.22.1902.1902

Published: 2016

Journal Articles

Differentiating Thrombotic Microangiopathies Based on Laboratory Tests Other Than ADAMTS13 Using Machine Learning Technology

Youngil Koh, MD PhD, SuYeon Lee, Hong-Seok Yun, Sung-Soo Yoon, MD PhD, Inho Kim, MD PhD, Byung-Su Kim, MD PhD, Doyeun Oh

Blood (2016) 128 (22): 3749.

https://doi.org/10.1182/blood.V128.22.3749.3749

Published: 2016

Journal Articles

Prognostic Impact of Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome

Blood (2016) 128 (22): 5432.

https://doi.org/10.1182/blood.V128.22.5432.5432

Published: 2016

Journal Articles

Improved Sensitivity in Detection of FMS-like Tyrosine Kinase Internal Tandem Duplication of a Method Using Next-Generation Sequencing Data

Junghoon Shin, MD, Daeyoon Kim, MS, Yoojin Hong, Youngil Koh, MD PhD, Hongseok Yun, Dong-Yeop Shin, MD PhD, Sung-Soo Yoon, MD PhD, Inho Kim, Junglim Lee, MD, Byung-Su Kim, MD PhD

Blood (2016) 128 (22): 2844.

https://doi.org/10.1182/blood.V128.22.2844.2844

Published: 2016

Journal Articles

Quality-of-Life and Health Behaviors in Survivors of Acute Leukemia Compared with the General Population: A Population-Based Matched Case-Control Study

Koung Jin Suh, Dong-Yeop Shin, MD PhD, Inho Kim, Sung-Soo Yoon, Jeong-Ok Lee, Soo-Mee Bang, Ki Hwan Kim, Jin Hyun Park, Sang Min Park, Youngae Kim, Young Ho Yun, Youngil Koh, MD PhD

Blood (2016) 128 (22): 5981.

https://doi.org/10.1182/blood.V128.22.5981.5981

Published: 2016

NARROW

Prognostic Significance of Interim PET/CT Assessment for the Treatment of Advanced Stage of Marginal Zone Lymphoma in the Post Immunochemotherapy Era

A Nationwide Epidemiologic Study for Disease Transformation and Secondary Cancers in Korean Patients with Myeloproliferative Neoplasms

Genomic and Immune Profiles of Multiple Myeloma Revealed By Whole Genome and Transcriptome Sequencing

Mosunetuzumab, a Full-Length Bispecific CD20/CD3 Antibody, Displays Clinical Activity in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (NHL): Interim Safety and Efficacy Results from a Phase 1 Study

Exon Skipping of AIMP2 and Lymphomagenesis

Anticoagulation Treatment with Low Molecular-Weight Heparin for Portal Vein Thrombosis in Liver Cirrhosis: Efficacy and Risk of Hemorrhagic Complications

A Phase II Trial of Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-Cell Lymphoma (BENCART): A Consortium for Improving Survival of Lymphoma (CISL) Trial

Decitabine Is Superior to Cytotoxic Chemotherapy in Elderly Acute Myeloid Leukemia Patients in Terms of Medical Source Utilization and Cost-Effectiveness without Negatively Impacting Survival Outcomes

Real World Treatment Outcomes of Multiple Myeloma in Korea

Analysis of Adverse Events of Dasatinib and Nilotinib in Chronic Phase Chronic Myeloid Leukemia Patients Treated Outside Clinical Trials

Differentiating Thrombotic Microangiopathies Based on Laboratory Tests Other Than ADAMTS13 Using Machine Learning Technology

Prognostic Impact of Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome

Improved Sensitivity in Detection of FMS-like Tyrosine Kinase Internal Tandem Duplication of a Method Using Next-Generation Sequencing Data

Quality-of-Life and Health Behaviors in Survivors of Acute Leukemia Compared with the General Population: A Population-Based Matched Case-Control Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only